Clinical Trials on Refractory Solid Malignancies
Total 9456 results
-
Kiromic, Inc.TerminatedCancer | Progressive Solid Malignancies | Refractory Solid MalignanciesUnited States
-
National University Hospital, SingaporeRecruitingMetastatic Solid Malignancies | Advance Solid MalignanciesSingapore
-
AHS Cancer Control AlbertaCross Cancer InstituteWithdrawnMetastatic Solid Malignancies | Locally Advanced Solid MalignanciesCanada
-
Curon Biopharmaceutical (Australia) Co Pty LtdNovotech (Australia) Pty LimitedTerminatedRelapsed Lymphoid Malignancies | Refractory Lymphoid MalignanciesAustralia
-
University of Southern CaliforniaTerminated
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedMetastatic Solid Tumors, Refractory/Relapsed Hematologic MalignanciesUnited States
-
St. Jude Children's Research HospitalNovartis PharmaceuticalsCompletedRecurrent or Refractory Solid Tumors | CNS MalignanciesUnited States
-
SCRI Development Innovations, LLCNovartisCompletedAdvanced Malignancies | Refractory MalignancyUnited States
-
National Taiwan University HospitalNot yet recruitingRelapsed/Refractory B-Cell Malignancies
-
AstraZenecaQuintiles, Inc.CompletedSolid MalignanciesUnited Kingdom
-
University Hospital, Clermont-FerrandAmgenTerminatedSolid Malignancies
-
AstraZenecaCompletedCancer | Solid Tumors | Advanced Solid MalignanciesJapan
-
AstraZenecaTerminatedCancer | Solid Tumors | Advanced Solid MalignanciesJapan
-
Haisco Pharmaceutical Group Co., Ltd.RecruitingRelapsed/Refractory B-Cell MalignanciesChina, Australia
-
Minghui Pharmaceutical (Shanghai) LTDRecruitingRelapsed/Refractory B-cell MalignanciesChina
-
Gilead SciencesCompletedRelapsed/Refractory B-cell MalignanciesFrance, United Kingdom
-
OncoMed Pharmaceuticals, Inc.CompletedRelapsed or Refractory Lymphoid MalignanciesUnited States
-
Eli Lilly and CompanyChildren's Oncology GroupCompletedRecurrent Tumor | Pediatric Solid Tumor | Refractory Tumor | CNS MalignanciesUnited States
-
University Hospital, Clermont-FerrandAmgenUnknown
-
Zhuhai Yufan Biotechnologies Co., LtdRecruitingAdvanced Solid Tumor | Advanced Solid MalignanciesChina
-
Zhuhai Yufan Biotechnologies Co., LtdRecruitingAdvanced Solid Tumor | Advanced Solid MalignanciesUnited States
-
AstraZenecaActive, not recruitingAdvanced Solid MalignanciesJapan
-
AstraZenecaActive, not recruitingAdvanced Solid MalignanciesRomania, Moldova, Republic of
-
Novartis PharmaceuticalsCompletedAdvanced Solid MalignanciesNetherlands
-
Samyang Biopharmaceuticals CorporationCompleted
-
Washington University School of MedicineCompletedResistant Solid MalignanciesUnited States
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited Kingdom
-
Geron CorporationCompletedSolid Tumor MalignanciesUnited States
-
Regeneron PharmaceuticalsSanofiCompletedAdvanced Solid MalignanciesUnited States
-
AstraZenecaCompletedAdvanced Solid MalignanciesChina
-
Mayo ClinicGlaxoSmithKlineCompletedAdvanced Solid MalignanciesUnited States
-
Gilead SciencesRecruiting
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruiting
-
R-PharmCompletedSolid MalignanciesUnited States
-
University of KentuckyArno TherapeuticsCompleted
-
Sigma-Tau Research, Inc.Dana-Farber Cancer Institute; Rhode Island HospitalCompletedSolid MalignanciesUnited States
-
AstraZenecaTerminatedSolid Tumors | Advanced Solid Malignancies | Cancer,United States
-
Acrotech Biopharma Inc.Axis Clinicals LimitedTerminatedRelapsed/Refractory Solid Tumors/Hematological MalignanciesUnited States
-
Athenex, Inc.RecruitingAdvanced Solid MalignanciesUnited States
-
Carrick Therapeutics LimitedCompletedAdvanced Solid MalignanciesUnited States, United Kingdom
-
Novartis PharmaceuticalsCompletedAdvanced Solid MalignanciesFrance, Spain, Canada
-
AstraZenecaCompletedAdvanced Solid MalignanciesJapan
-
AstraZenecaCompletedAdvanced Solid MalignanciesJapan
-
Taipei Medical UniversityCompletedAdvanced Solid MalignanciesTaiwan
-
Synta Pharmaceuticals Corp.CompletedSolid Tumor MalignanciesUnited States
-
Washington University School of MedicineCompletedResistant Solid MalignanciesUnited States
-
Hanmi Pharmaceutical Company LimitedCompletedAdvanced Solid MalignanciesKorea, Republic of
-
AstraZenecaCompleted10mg ZD4054 (Zibotentan) PK Study in Male, Elderly Chinese Patients With Advanced Solid MalignanciesAdvanced Solid MalignanciesChina
-
Bristol-Myers SquibbTerminatedAdvanced Solid MalignanciesUnited States, Canada
-
Weill Medical College of Cornell UniversityTerminatedSolid Tumor MalignanciesUnited States